Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « June » « 2025 » M T W T F S S 26 27 28 29 30 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4 5 6   - « June » « 2025 » M T W T F S S 26 27 28 29 30 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4 5 6   Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Mori, Shahram
OV-AML-1231, NCT06384261: A Study Comparing Venetoclax and Azacitidine Plus Cusatuzumab to Venetoclax and Azacitidine in Newly Diagnosed AML Ineligible for Intensive Therapy	Recruiting	2	120	Europe, Canada, US	Cusatuzumab, OV-1001, Venetoclax, Azacitidine	OncoVerity, Inc.	Leukemia, Myeloid, Acute	01/27	06/27
NCT04284228: Antigen-specific T Cell Therapy for AML or MDS Patients With Relapsed Disease After Allo-HCT	Active, not recruiting	1/2	22	US	Infusion of NEXI-001 T Cells	NexImmune Inc.	Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS)	10/24	03/25

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Mori, Shahram
OV-AML-1231, NCT06384261: A Study Comparing Venetoclax and Azacitidine Plus Cusatuzumab to Venetoclax and Azacitidine in Newly Diagnosed AML Ineligible for Intensive Therapy	Recruiting	2	120	Europe, Canada, US	Cusatuzumab, OV-1001, Venetoclax, Azacitidine	OncoVerity, Inc.	Leukemia, Myeloid, Acute	01/27	06/27
NCT04284228: Antigen-specific T Cell Therapy for AML or MDS Patients With Relapsed Disease After Allo-HCT	Active, not recruiting	1/2	22	US	Infusion of NEXI-001 T Cells	NexImmune Inc.	Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS)	10/24	03/25